Lv41
446 积分 2024-07-08 加入
Design of Ig-like binders targeting α-synuclein fibril for mitigating its pathological activities
1小时前
待确认
α-Synuclein pathology as a target in neurodegenerative diseases
2小时前
已完结
Emerging targets of α-synuclein spreading in α-synucleinopathies: a review of mechanistic pathways and interventions
3小时前
已完结
Parkinson’s disease-associated PLA2G6 protects IP3R1 protein to control ER-mitochondria tethering and Ca2+ transfer
2天前
已完结
Chiral metal-organic frameworks incorporating nanozymes as neuroinflammation inhibitors for managing Parkinson’s disease
3天前
已完结
Nanotechnology for CAR T cells and tumour-infiltrating lymphocyte therapies
5天前
已完结
A monoclonal antibody targeting the C-terminal of α-synuclein fibrils mitigates pathology in a Parkinson’s disease model
16天前
已完结
Dual-action selenium nanodrugs confer synergistic protection against Parkinson’s Disease via mitochondrial-targeted antioxidant therapy and selenoprotein p-mediated selenium mobilization
3个月前
已完结
Metal–Organic Framework Based Nanozyme System for NLRP3 Inflammasome‐Mediated Neuroinflammatory Regulation in Parkinson's Disease
4个月前
已完结
Meningeal lymphatic drainage: novel insights into central nervous system disease
5个月前
已完结
皖公网安备34019202002308
